Healthcare >> CEO Interviews >> September 13, 2002
BASSIL I. DAHIYAT co-founded Xencor_ and has been President and Chief
Executive Officer and a director since August 1997. Prior to founding
Xencor, Dr. Dahiyat was a graduate student at Caltech, where he
developed the biophysical models and protein design tools that form the
basis of Xencor's biotherapeutics platform. Dr. Dahiyat holds a PhD in
Chemistry from Caltech and BS and MSE degrees in Biomedical Engineering
from Johns Hopkins University. He has co-authored numerous papers in the
fields of protein design and drug delivery, and has received scientific
awards from the American Chemical Society, the Controlled Release
Society, the Protein Society and Caltech. Profile
the company today?
Mr. Dahiyat: We are discovering novel therapeutic molecules for the
treatment of disease. We have been
